Drug Research
KaliVir Immunotherapeutics, Astellas ink research agreement to develop and commercialise VET2-L2 novel oncolytic virus
KaliVir Immunotherapeutics LLC and Astellas Pharma Inc announced that they entered into a worldwide licensing agreement for the research, development, and commercialization of VET2-L2, an...
News
Codex DNA Releases New Synthetic Genomes for the Fight Against COVID-19
Codex DNA, Inc. announced the release of seven new synthetic SARS-CoV-2 genomes for use in the development of vaccines, therapeutics, and diagnostics to help in...
News
Tjoapack invests over €10m into Etten-Leur facility
Global contract packaging organisation (CPO), Tjoapack, has announced a €10m+ investment into its packaging and supply chain facility in Etten-Leur, Netherlands over the next two...
News
Moderna Announces Amendment to Supply Agreement with the Ministry of Health of Israel to Supply Additional Doses of mRNA Vaccine Against COVID-19
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced an expanded...
News
Amgen and McKesson Launch Strategic Agreement to Advance Cancer Innovation in Communities
McKesson and Amgen, one of the world’s leading biotechnology companies, have signed a strategic agreement to help improve cancer care in community oncology settings. Today,...
Clinical Trials
Kaneka Eurogentec will manufacture INOVIO’s DNA vaccine candidate against COVID-19
INOVIO has assembled a global coalition of collaborators, partners and funders to rapidly advance the development of INO-4800, a DNA vaccine against the novel coronavirus...
Drug Research
Lilly and UnitedHealth Group partner on pragmatic study of neutralizing antibody bamlanivimab for COVID-19
Eli Lilly and Company and UnitedHealth Group announced a partnership to conduct a pragmatic study of bamlanivimab (LY-CoV555) in high-risk, COVID-19 infected individuals.
Bamlanivimab recently received...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.